1. Patients and tumor characteristics
There were 46 patients with radial malignant tumor which accounting for 17.3% of 266 patients with radial tumor, 22 patients with ulna malignant tumor which accounting for 21.4% of 103 patients with ulna tumor. The number of malignant tumor in ulna was less than that in radius.
In 46 patients with primary malignant bone tumor of radius, limb salvage surgery was performed in 40 patients and amputation in 6 patients. In 22 patients with malignancy of ulna, limb salvage surgery was executed in 20 patients and amputation in 2 patients. A total of 60 patients were carried out limb salvage surgery. Fifty-six patients followed more than 12 months or progressions within 12 months were included in final evaluation (Table 1). There were 34 males (60.7%) and 22 females (39.3%) with mean age of 27.8 (5–73, median 20.0) years. The follow-up averaged 72.1 (7-192, median 62.5) months.
Table 1
Patients, Tumor Characteristics and Outcomes in 56 Patients
Characteristics | N (%) | Local recurrence | Metastasis | Death |
Gender | | | | |
Male | 34(61) | 8 | 11 | 9 |
Female | 22(39) | 3 | 3 | 3 |
Age | | | | |
< 50 | 48(86) | 10 | 12 | 10 |
≥ 50 | 8(14) | 1 | 2 | 2 |
Major histologic type | | | | |
Osteosarcoma | 17(30) | 3 | 6 | 5 |
Ewing sarcoma | 10(18) | 2 | 3 | 3 |
Pleomorphic undifferentiated sarcoma | 7(13) | 1 | 2 | 2 |
chondrosarcoma | 6(11) | 1 | 0 | 0 |
Other than above | 16(28) | 4 | 3 | 2 |
Status at presentation | | | | |
Virgin | 41(73) | 5 | 9 | 8 |
Unplanned resection | 15(27) | 6 | 5 | 4 |
Grade | | | | |
Low | 17(30) | 4 | 2 | 2 |
High | 39(70) | 7 | 12 | 10 |
Involved bone | | | | |
Radius | 38(68) | 4 | 10 | 9 |
Ulna | 18(32) | 7 | 4 | 3 |
Anatomic location | | | | |
Proximal 1/3 | 19(34) | 7 | 7 | 6 |
Middle 1/3 | 10(18) | 2 | 1 | 1 |
Distal 1/3 | 27(48) | 2 | 6 | 5 |
Bone Resection | | | | |
defect < 1/3 | 18(32) | 3 | 5 | 4 |
1/3 ≤ defect < 2/3 | 24(43) | 6 | 6 | 5 |
2/3 ≤ defect | 14(25) | 2 | 3 | 3 |
Margin | | | | |
Intracapsular | 3(5) | 2 | 1 | 1 |
Marginal | 8(14) | 5 | 5 | 4 |
Wide | 45(81) | 4 | 8 | 7 |
Chemotherapy | | | | |
Neoadjuvant | 28(50) | 5 | 9 | 8 |
Adjuvant | 33(59) | 7 | 10 | 8 |
No chemo | 23(41) | 4 | 4 | 4 |
Thirty-eight (38/56, 67.9%) patients underwent radius resection. Location was at proximal radius in 6 patients, shaft in 7 patients, and distal radius in 25 patients. Eighteen (18/56, 32.1%) patients underwent ulna resection. Location was at proximal ulna in 13 patients, shaft in 3 patients, and distal ulna in 2 patients. In general, there were 19 cases (33.9%) in proximal 1/3, 10 cases (17.9%) in middle 1/3, and 27 cases (48.2%) in distal 1/3 of the forearm.
Based on pathological diagnosis, osteosarcoma was in 17 patients (30.4%), Ewing's sarcoma in 10 patients (17.9%), undifferentiated pleomorphic sarcoma in 7 patients (12.5%), low-grade central osteosarcoma in 6 patients (10.7%), chondrosarcoma in 6 patients (10.7%), bone angiosarcoma in 2 patients (3.6%), epithelioid sarcoma in 2 patients (3.6%), parosteal osteosarcoma, low-grade mixed tumor, low grade myofibroblastic sarcoma, malignant giant cell tumor of bone, spindle cell sarcoma and clear cell sarcoma in 1 patient (1.8%), respectively. There were 17 cases (30.4%) of low-grade sarcoma and 39 cases (69.6%) of high-grade sarcoma based on histology [4, 5]. Forty-one patients (73.2%) received initial operation in our hospital and 15 patients (26.8%) were referral to other hospitals after unplanned resection. The length diameter of recurrent lesion in 15 patients with unplanned resection was significantly larger than that of virgin tumor (P = 0.001). Twenty-eight high-grade bone tumors which contained osteosarcoma (16/17), Ewing's sarcoma (10/10) and undifferentiated pleomorphic sarcoma (2/5) received preoperative chemotherapy. Thirty-three of 39 cases of high-grade sarcoma were administered by postoperative chemotherapy.
The surgical margin contained intracapsular resection in 3 cases (5.3%), marginal resection in 8 cases (14.3%) and wide resection in 45 cases (80.4%). Reconstructions were performed in 48 patients (85.7%). Postoperative radiotherapy was not performed in each patient. The bone defect contained 1/3 defect in 18 patients (32.1%), 2/3 in 24 patients (42.9%) and more than 2/3 in 14 patients (25%). The reconstruction methods of radius defect included: autogenous iliac bone graft and wrist joint fusion, autogenous fibula transplantation, ulna centralization and wrist joint fusion, ulna osteotomy and replacement of radial defect. The reconstruction methods of ulna defect included: elbow prosthesis replacement, vascularized fibula transplantation, elbow arthroplasty with humerus and radius, inactivated replantation. Among the 48 patients underwent reconstruction, rotation function of forearm was preserved in 26 patients and lost in 22 patients. The wrist joint fusion was performed in 19 patients and elbow arthroplasty was performed in 6 patients.
2. Tumor local control
Local recurrence occurred in 11 patients (19.6%) (Table 2). The recurrence rate of reoperation in patients who underwent unplanned resection was 40% (6/15), which was higher than virgin tumor (12.2%, 5/41) (P = 0.02) (Fig. 1). The median recurrence free time of 11 recurrent cases was 12 (2–38) months and 90% of the recurrences occurred within 3 years (10/11). Amputation was performed in 4 cases (36.4%). The local resection was performed in 7 cases (63.6%) and 1 case had a second recurrence. The 3-year and 5-year recurrence free survival rates were 81.9% and 79.8% respectively. The recurrence rate with inadequate margin was significantly higher than that adequate resection. Univariate analysis (Table 3) showed history of unplanned resection (P = 0.015), ulna tumor (P = 0.016), tumor located in proximal forearm (P = 0.021), and inadequate surgical margin (P < 0.001) were associated with recurrence (Fig. 2).
Table 2
Local Recurrences by Tumor Type, Grade, Location, Margins
No | Histology | Post-op interval | Grade | Bone | Location | Status | Margin | Outcome | Follow-up months |
1 | Osteosarcoma | 2 | High | Radius | Distal 1/3 | Unplanned excision | Inadequate | Death | 7 |
2 | Osteosarcoma | 38 | High | Radius | Distal 1/3 | Virgin | Inadequate | NED | 123 |
3 | Spindle cell sarcoma | 11 | Low | Radius | Distal 1/3 | Unplanned excision | Inadequate | Death | 19 |
4 | Ewing sarcoma | 12 | High | Ulna | Proximal 1/3 | Virgin | Adequate | Death | 24 |
5 | Ewing sarcoma | 28 | High | Ulna | Proximal 1/3 | Unplanned excision | Adequate | Death | 40 |
6 | Osteosarcoma | 5 | High | Ulna | Middle 1/3 | Virgin | Inadequate | Death | 92 |
7 | Chondrosarcoma | 24 | Low | Ulna | Proximal 1/3 | Virgin | Inadequate | NED | 48 |
8 | Low grade central osteosarcoma | 27 | Low | Ulna | Proximal 1/3 | Virgin | Adequate | NED | 42 |
9 | Clear cell sarcoma | 5 | Low | Radius | Proximal 1/3 | Unplanned excision | Inadequate | Death | 11 |
10 | Pleomorphic undifferentiated sarcoma | 16 | High | Ulna | Proximal 1/3 | Unplanned excision | Adequate | NED | 43 |
11 | Epithelioid sarcoma | 11 | High | Ulna | Proximal 1/3 | Unplanned excision | Inadequate | SWT | 30 |
Inadequate: Intracapsular and Marginal; Adequate: Wide; NED: No evidence of disease; SWT: Survival with tumor |
Table 3
Outcomes in Univariate Analysis of Prognostic Factors (n = 56)
Variable | Local recurrence-free survival (%) | Distant metastasis-free survival (%) | Disease specific overall survival (%) |
Gender | | | | |
| Male | 76.1 | 64.6 | 65.6 |
| Female | 85.6 | 86.4 | 86.4 |
| P value | 0.377 | 0.152 | 0.392 |
Age | | | | |
| < 50 | 78.8 | 74.1 | 74.2 |
| ≥ 50 | 85.7 | 65.6 | 43.8 |
| P value | 0.620 | 0.986 | 0.609 |
Grade | | | | |
| Low | 76.5 | 88.2 | 88.2 |
| High | 81.4 | 67.0 | 67.7 |
| P value | 0.651 | 0.178 | 0.427 |
Bone Site | | | | |
| Radius | 88.9 | 71.0 | 71.8 |
| Ulna | 66.1 | 77.8 | 66.1 |
| P value | 0.016 | 0.762 | 0.662 |
Anatomic location | | | | |
| Proximal 1/3 | 62.3 | 51.3 | 48.1 |
| Middle & Distal 2/3 | 88.3 | 80.1 | 79.5 |
| P value | 0.021 | 0.119 | 0.065 |
Status | | | | |
| Virgin | 87.0 | 74.3 | 72.2 |
| Unplanned resection | 60.0 | 66.7 | 72.7 |
| P value | 0.015 | 0.419 | 0.409 |
Margin | | | | |
| Adequate | 90.8 | 80.4 | 80.9 |
| Inadequate | 36.4 | 43.6 | 48.5 |
| P value | 0.000 | 0.008 | 0.048 |
Chemotherapy | | | | |
| Neoadjuvant & Adjuvant | 78.2 | 79.1 | 70.8 |
| No chemo | 82.2 | 68.7 | 72.5 |
| P value | 0.741 | 0.321 | 0.833 |
Local recurrence | | | | |
| Yes | NA | 36.4 | 26.5 |
| No | NA | 82.2 | 81.8 |
| P value | NA | 0.000 | 0.000 |
Metastasis | | | | |
| Yes | NA | NA | 0 |
| No | NA | NA | 100 |
| P value | NA | NA | 0.000 |
3. Distant metastasis and overall survival
Distant metastasis was observed in 14 patients (14/56, 25%) and 12 (12/14, 85.7%) of them were with high-grade malignant tumor. The median time to the development of distant metastasis was 15 (2–64) months with 8 (57.1%) metastasis occurring within 1.5 years after surgery and 12 cases (85.7%) within 2 years. The median time to death after development of distant metastasis was 11 (1–84) months. Eleven cases (78.6%) involved only lung metastasis, 3 cases (21.4%) involved multiple sites of lung and bone metastases (1 scapula, 1 thoracic vertebra and 1 femoral shaft). The 2-year and 5-year metastasis free survival rates were 78.6% and 76.0% respectively. The metastasis free survival rates with different surgical margins were 80.4% and 43.6%, respectively (P = 0.008) (Fig. 3). The 5-year survival rates of high-grade and low-grade tumors were 81.7% and 88.2%, respectively (P = 0.427). At the last follow-up, 42 patients survived without tumor, 2 patients survived with tumor and 12 patients died. The median survival time of dead patients was 29 (7–92) months. The overall 5-year and 10-year survival rates were 83.5% and 71.7%, respectively (Fig. 4). Univariate analysis showed inadequate surgical margin (P = 0.048), local recurrence (P < 0.001) and distant metastasis (P < 0.001) were associated with death. Multivariate analysis of risk ratio model showed recurrence and distant metastasis were independent significant predictor of overall survival.
4. Postoperative complications and functional evaluation
Ten patients (17.8%) developed postoperative complications: internal fixation failure in 5 patients, limb short deformity, wrist silver fork deformity, prosthetic aseptic loosening, inactivated bone graft joint subluxation and bone graft nonunion in 1 patient respectively. Seven patients (70%) underwent revision: 5 patients with fixation failure received re-fixation, 1 patient with nonunion received iliac graft again, and 1 patient with short limb deformity received limb extension by external fixator. The other 3 patients carried out routine observation without revision.
The bone defect after radial tumor resection were divided into proximal 1/3, distal 1/3 and middle 2/3 defect. The proximal 1/3 defect didn’t receive reconstruction (Fig. 5-A). The distal 1/3 defect receive autogenous iliac bone graft and wrist joint fusion with internal fixation (Fig. 5-B). The middle 2/3 defect received following methods: (1) ulna osteotomy and fixation with the end of radius (Fig. 5-C), (2) ulna centralization and wrist joint fusion with internal fixation (Fig. 5-D), (3) long segment fibula autograft and fixation (Fig. 5-E), (4) ipsilateral ulnar osteotomy to replace the radial defect (Fig. 5-F)
After resection of ulna tumor, the proximal 1/3 defect was treated with (1) elbow prosthesis replacement, (2) inactivated replantation. More than 2/3 defect of middle segment was treated with (1) elbow prosthesis combined with free vascularized fibula grafting (Fig. 5-G), (2) brachioradial elbow arthroplasty (Fig. 5-H). The distal 1/3 defect didn’t receive reconstruction (Fig. 5-I). Twenty-two patients with ulna centralization lost rotation function, but flexion/extension and other fine movements were not significantly limited. At the last follow-up, 42 patients were evaluated by MSTS score with an average of 93.0 ± 5.1%. The function of patients with limb salvage was satisfactory and the final limb salvage rate was 92.9% (52/56).